Clinical Trial Update: Arrhythmia Genetics in the NEtherlandS

View source ↗

Summary

A clinical trial update from Amsterdam UMC on arrhythmia genetics in the Netherlands, focusing on patients with myocardial infarction and ventricular fibrillati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Ventricular Fibrillation

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Myocardial Infarction First, Ventricular Fibrillation | Status: UNKNOWN